Decoy Therapeutics Inc. (DCOY) Financials
DCOY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.0 million | 4.7 million |
| March 31, 2026 | 8.4 million | 4.5 million |
| Dec. 31, 2025 | 11.1 million | 5.2 million |
| Sept. 30, 2025 | 6.1 million | 1.8 million |
DCOY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.7 million | 206177 |
| March 31, 2026 | -2.9 million | 213044 |
| Dec. 31, 2025 | -1.1 million | 139523 |
| Sept. 30, 2025 | -1.6 million | 22846 |
DCOY Net Income
No data available :(
DCOY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 8.3 million | - | - |
| March 31, 2026 | 7.8 million | - | - |
| Dec. 31, 2025 | 10.7 million | - | - |
| Sept. 30, 2025 | 4.8 million | - | - |
DCOY Shares Outstanding
DCOY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 42424 | 1.3 million | 1.3 million | - |
| March 31, 2026 | - | 749813 | 1.5 million | - |
| Dec. 31, 2025 | 2 | 114429 | 403273 | - |
| Sept. 30, 2025 | - | 61826 | 833304 | - |
DCOY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | 8.5 million |
| Sept. 30, 2025 | - | - |
DCOY Revenue by Segment
Graph available only for paid members. Upgrade to see it.
DCOY
Price: $3.72
52 week price:
Earnings Per Share: -24.24 USD
P/E Ratio: -0.03
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.2 million